You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
偉思醫療(688580.SH):積極探索AI技術在生物反饋、腦功能、康復機器人,康復物理因子領域的運用場景
格隆匯 03-13 15:38

格隆匯3月13日丨偉思醫療(688580.SH)在投資者互動平臺表示,公司現有的產品設計已積極運用智能化技術,提升產品自動化和智能化水平:例如:①經顱磁刺激儀(MagNeuro ONE系列):引入AI驅動的腦部影像處理系統,實現治療靶點的精準定位與劑量智能調節,爲高端臨牀和科研提供最領先的經顱磁技術;②3A射頻機器人:結合高精度圖形識別算法與實時溫度控制技術,實現治療路徑自動化與過程可視化,推動射頻治療進入智能化時代;③塑形磁PMS:採用RMM智能氣囊技術,智能化自動評估肌肉訓練狀態,自動監測和調整訓練強度,以確保使用者能夠達到最佳的訓練效果。人工智能作爲新一輪產業變革的核心驅動力,正加速融入醫療設備研發領域,公司將密切關注新興技術的應用潛力,持續加強AI智能化技術在公司產品研發投入與技術創新中的應用,充分利用人工智能技術賦能企業升級發展,例如:①利用AI算法對焦慮症、兒童多動症、抑鬱症等病症的生物反饋數據進行實時分析,輔助臨牀決策;②通過AI技術優化激光能量管理平臺,解決溫度控制、自動化操作等核心問題;③積極探索AI技術在生物反饋、腦功能、康復機器人,康復物理因子領域的運用場景,助力康復理療進入智能化時代。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account